# Lefamulin for M. Genitalium Treatment Failures

> **NCT05111002** · PHASE1,PHASE2 · TERMINATED · sponsor: **University of Washington** · enrollment: 12 (actual)

## Conditions studied

- Mycoplasma Genitalium Infection

## Interventions

- **DRUG:** Lefamulin
- **DRUG:** Doxycycline

## Key facts

- **NCT ID:** NCT05111002
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-04-22
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** At Sponsor Request
- **Last updated:** 2024-10-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05111002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05111002, "Lefamulin for M. Genitalium Treatment Failures". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05111002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*